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Abstract
Background: Bacterial meningitis is a group of life threatening infections that mostly affect
children and adolescents, and may be the cause of severe neurological sequelae. Cuba has
implemented massive vaccination programmes against both Neisseria meningitidis (serogroup C in
1979 and B in 1987), and Haemophilus influenzae type b (1999), two of the main causal pathogens.
We described and discussed some epidemiological aspects of the current status of bacterial
meningitis to learn from the Cuban experience.
Methods: A nationwide observational study on children and adolescents from 1 to 18 years old
was carried out from 1998 to 2003, estimating the incidence and case-fatality rate by age group and
causal pathogens, as well as the seasonality and frequency of overcrowded dormitories. The
association between disease and attendance to day care centres or boarding schools was estimated
by using relative risk (Chi-squared test and Fisher Exact Test).
Results: The overall number of cases was 1023; the incidence ranged from 3.4 to 8.5 per 100 000
population, with the higher figures in children 1–5 years old (16.8 per 100 000 population).
Streptococcus pneumoniae, Haemophilus influenzae type b and Neisseria meningitidis serogroup B were
the main identified agents. The average case-fatality rate was 10.5% and the most lethal agents were
Streptococcus pneumoniae (27%) and Haemophilus influenzae type b (10.7%). Overall percentage of
cases who slept in overcrowded dormitories was 15%, reaching 30.6% in adolescents. Seasonality
was only evident among meningococcal meningitis cases between September–October. The
attendance to boarding high school showed an association with disease only in 1998 and 1999 (RR
= 2.1; p > 0.05).
Conclusion: The highest incidence of bacterial meningitis was observed among children from 1–
5 years old. Pneumococcus was both the leading causal and the most lethal agent. Sleeping in
overcrowded dormitories was more frequent among adolescents. No strong association was
observed between the bacterial meningitis and attendance to day care centres or boarding schools.
The incidence of bacterial meningitis in Cuba is declining after massive vaccination programmes
against Neisseria meningitidis serogroup B and C and Haemophilus influenzae type b through a
national immunisation program.
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Bacterial meningitis (BM) is a group of severe infections
that frequently affect children and adolescents, carrying a
high case-fatality rate (CFR). It may cause transient or per-
manent deafness as well as other severe neurological
sequelae in survivors [1-3].
The World Health Organisation estimated that annually
BM causes at least 1.2 million cases worldwide and of
those 135 000 deaths. Though other bacteria may cause
BM, Neisseria meningitidis, Haemophilus influenzae type b
(Hib) and Streptococcus pneumoniae (Spn) are the main
triad responsible for more than 80% of all cases. Gram
negative bacteria, particularly E. coli, Streptococci (different
from S. pneumoniae), Listeria monocitogenes and Staphyloco-
cci may also cause BM [3].
BM has been reported in Cuba since the beginning of the
20th century [4]. The mandatory report of this group of
infections has been implemented since 1961 as part of
national communicable diseases surveillance.
Following a meningococcal disease epidemic in 1979, an
independent surveillance system was put into place [4].
After controlling the epidemic, other germs like Hib and
Pneumococcus increased their aetiological importance. In
1997 public health authorities decided to extend the sur-
veillance to all bacteria, as well as to improve epidemio-
logical and microbiological data through the Bacterial
Meningitis National Surveillance System (BMSS) [5]. This
allowed a high level of accuracy and quality information
to be collected which could be compared with high sur-
veillance systems international standards [5-8].
On the other hand, Cuba is the only country in the world
which has carried out massive vaccination initiatives
against Neisseria meningitidis serogroup C (1979) and B
(1987) [9], and later in 1999 against Hib [10], both as
part of the national immunisation program (NIP).
The aim of this study was to describe and discuss the
results of both, the BMSS and the massive vaccination
strategies, on the epidemiology of BM in Cuban children
and adolescents.
Methods
1023 cases of BM in the Cuban population between 1–18
years old reported nationwide by BMSS from January 1st
1998 to December 31st 2003 were included in the study,
considering the date of the symptoms onset.
Children under 1 years old were not included in the study
based on the criteria that they should be considered a spe-
cial group for the following reasons: breast-feeding,
immune maturation, they usually do not attend day care
and do not have much community contact.
We defined a case of BM as "a clinical meningeal syn-
drome, through the identification of the causal agent
directly by culture blood, petecchias, cerebrospinal fluid
(CSF) analysis or indirectly by polymerase chain reaction,
latex test or another rapid diagnostic test. The cases with
negative culture or bacteriological test, but the cyto-chem-
ical exam of the CSF suggested bacterial infection, were
considered BM of "unknown aetiology" [11].
A total of 4 age groups which coincided with the main
level of education in Cuba were selected: the group 1–5
year olds which attended day care centres (DCC) was con-
sidered as small children; 6–11 year olds were considered
older children (Primary School). More than 11 year olds
were considered adolescents, attending High School those
12–14 year olds and to College, Technical or Professional
Education those 15–18 year olds.
The incidence rate (new cases per 100 000 population)
and CFR (percent) were calculated according to the age
group and to the main causal agent, using the data of esti-
mated Cuban population of the Office for National Statis-
tics in Cuba. The seasonality by monthly average for each
causal agent and the frequency of cases who slept in over-
crowded dormitories by age group were also estimated.
Comparisons were carried out using Chi-squared tests
with a significance level of 0.05.
Relative Risk (RR) was estimated and its confidence inter-
val with p < 0.05 considered as significant, using either a
Chi-squared Test or Fisher's Exact Test as appropriate. We
considered exposed to community settings the cases
attending DCC or boarding school, and not exposed those
who do not attend these institutions. The national matric-
ulation and registration of school children and adoles-
Table 1: Overall Incidence and Case-Fatality Rate (CFR) for 
bacterial meningitis* by age group in Cuba from 1998–2003.
Age group 1998 1999 2000 2001 2002 2003
1–5 yrs 16.8 15.3 11.1 8.5 4.7 6.2
6–11 yrs 3.3 7.4 4.1 3.7 3.3 4.6
12–14 yrs 1.6 5.9 3.7 3.5 4.3 4.1
15–18 yrs 3.7 4.5 4.5 2.9 1.7 2.0
Overall Incidence 6.5 8.5 5.8 4.6 3.4 4.2
Overall CFR 7.8 9.0 13.6 13.6 8.7 10.9
* Bacterial meningitis caused by Streptococcus pneumoniae, Neisseria 
meningitidis, Haemophilus influenzae type b, other identified bacteria 
and bacterial meningitis of unknown aetiology.Page 2 of 7
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Ministry of Education (MINED). RR in primary school
children was not estimated because the boarding student
matriculate between 1998–2003 was not available.
We used Epi-Info (version 6.2a) and Excel (version 5.1)
for the statistical analysis, and Microsoft Word 2000 as the
text processor program.
Results
A total of 1023 cases of BM between 1998–2003 were
reported. The overall incidence rose significantly from 6.5
per 100 000 population in 1998 to 8.5 per 100 000 pop-
ulation in 1999, but it subsequently decreased to 4.2 per
100 000 population in 2003 (Table 1).
The incidence of all age groups increased significantly in
1999, with the exception of small children, where there
was a peak in 1998 (16.8/100 000 population), with a
subsequent decrease. The group 1–5 year olds showed the
highest incidence of all. (Table 1)
An overall and by age group significant predominance of
male (63.2%) over female (46.8%) was observed in all the
groups (data not shown).
Spn, Hib and N. meningitidis were the main causal patho-
gens identified.
In 1998 Hib showed the highest incidence (3.0 per 100
000 population), but dropped significantly by approxi-
mately half (1.6 per 100 000 population) after the vacci-
nation programme in 1999 with a conjugated vaccine
(Vaxem-Hib®). The greatest decrease of incidence was
observed in small children, from 10.7 per 100 000 popu-
lation in 1999 to 5.7 per 100 000 population in 2000 (p
< 0.05). Only 8 cases have been reported since 2002
(Table 2).
The overall incidence of pneumococcal meningitis was
nearly 1 per 100 000 population, but a significant increase
occurred in 1999 and 2000 (1.3 and 1.4 per 100 000 pop-
ulation respectively) and subsequently decreasing. A sim-
ilar pattern in the incidence was observed in all age groups
with the exception of adolescents from 15–18 years old.
The small children showed the highest incidence of all
groups, mainly in 1998 (2.8 per 100 000 population) and
in 1999 (2.9 per 100 000 population), decreasing in 2001
and 2002, with a discreet subsequent increase in 2003
(2.3 per 100 000 population). Since the year 2000 Spn has
shown the highest incidence of all the identified bacteria
(Table 2).
Neisseria meningitidis was one of the three main causal
pathogens of BM, but the overall incidence remained
Table 2: Overall and by age group Incidence and Case-Fatality 
Rate (CFR) of bacterial meningitis according to the aetiology. 
Cuba. 1998–2003.
Streptococcus pneumoniae
Age group 1998 1999 2000 2001 2002 2003
1–5 yrs 1.6 2.8 2.9 2.0 1.9 2.3
6–11 yrs 0.3 0.9 0.9 0.6 0.2 0.7
12–14 yrs 0.4 0.6 1.1 0.5 0.4 0.7
15–18 yrs 1.4 0.8 0.8 0.3 0.3 0
Overall Incidence 0.9 1.3 1.4 0.9 0.7 1.0
Overall CFR 20.0 13.1 28. 6 26.9 15.0 30.0
Neisseria meningitidis
Age group 1998 1999 2000 2001 2002 2003
1–5 yrs 1. 1 0.8 0.9 1.2 0.7 0.5
6–11 yrs 0.5 0.5 0.5 0.4 0.3 0.3
12–14 yrs 0.2 0.8 0.6 0.7 0.9 0.4
15–18 yrs 0.5 0.6 0.9 0.1 0.1 0.1
Overall Incidence 0.6 0.6 0.7 0.6 0.5 0.3
Overall CFR 0 10.5 4.7 0 7.1 0
H. influenzae type b
Age group 1998 1999 2000 2001 2002 2003
1–5 yrs 10.7 5.7 1.6 0.5 0.6 0
6–11 yrs 0.7 0.4 0.2 0 0 0.1
12–14 yrs 0 0.2 0 0 0 0.2
15–18 yrs 0 0 0 0 0 0
Overall Incidence 3.0 1.6 0.5 0.1 0.2 0.1
Overall CFR 8.0 10.6 14.3 75.0 0 0
Unknown aetiology
Age group 1998 1999 2000 2001 2002 2003
1–5 yrs 4.6 6.2 4.7 4.3 1.3 2.2
6–11 yrs 2.7 5.6 2.1 2.6 1.9 2.8
12–14 yrs 1.2 3.4 1.1 2.2 3.0 2.1
15–18 yrs 1.7 3.0 3.4 2.3 1.2 1.7
Overall Incidence 2.7 4.8 2.9 2.9 1.8 2.3
Overall CFR 7.7 2.9 5.9 7.1 9.6 7.8Page 3 of 7
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cantly towards 2003. All the age groups showed subtle
variations of the incidence throughout the study period,
however only small children exceeded 1 per 100 000 pop-
ulation (Table 2). The overall ratio of meningitis/septicae-
mia for all groups was 3 per 1 (Data not shown). Neisseria
meningitis serogroup B was the only one isolated through-
out the study in the Neisseria Laboratory at the Institute
"Pedro Kourí" (IPK).
Regarding other identified bacteria, Staphylococcus sp.,
Streptococci (different from S. pneumoniae), E. coli and Sal-
monella were the most common pathogens. The frequency
of this group of bacteria was 43% in small children, 28%
in the older children, 13% in adolescents from 12–14 year
olds and 16% in adolescents from 15–18 year olds. Gram-
positive bacteria (63%) was significantly more frequent
than the gram-negative (37%) (Data not shown).
The average CFR of BM was nearly 10.5%. Overall CFR
showed variations, increasing significantly in 2000
(13.6%) and in 2001 (13.6%) when compared to 1998
(7.8%), with a subsequent significant decrease in 2003
(10.9%) (Table 1).
The most lethal pathogen was Spn with an average CFR =
27% (13–30%), followed by Hib with CFR = 10.7% (8–
75%) and Meningococcus B with CFR = 4% (4.7–10.5%).
The highest CFR (75%) observed in the period was caused
by Hib in 2001, but no cases have been reported subse-
quently (Table 2).
Bacterial meningitis of unknown aetiology accounted for
500 cases throughout the period. The overall incidence
showed a significant increase when compared in 1998
(2.7 per 100 000 population) to 1999 (4.8 per 100 000
population), as well as by age group. Only among small
children a significant decrease was observed, from 4.6 per
100 000 population in 1998 to 2.2 per 100 000 popula-
tion in 2003 (Table 2).
No seasonality was observed in pneumococcal and Hib
meningitis. Only meningococcal meningitis showed sea-
sonal behaviour with the highest peaks in September,
October and March (Figure 1).
Fifteen percent of overall BM cases slept in overcrowded
dormitories. This condition was observed in 10.1% of
children, and increased significantly in adolescents from
12–14 year olds and 15–18 year olds (30.6% and 24.6%
respectively) (Data not shown).
No association of BM with attendance to DCC or board-
ing school (including college, technical or professional
education) was observed during the study. Only in 1998
and 1999 did the attendance to boarding high school
show a strong association with disease (RR = 2.1; p > 0.05)
(Table 3).
Discussion
Prevention and control of infectious diseases, especially
among children and adolescents, has been a big concern
for the Public Health Ministry (PHM) in Cuba. Hitherto
vaccines are the most promising prospect for the preven-
tion of community acquired BM. Therefore widespread
use of effective vaccines may induce a major impact in
preventing the disease, especially when they are used dur-
ing a long period of time as a part of the NIP, as occurred
in Cuba, where a decreasing trend of BM has been docu-
mented after vaccination against meningococcus sero-
group B and C, and more recently, Hib [4,9,10,12].
Cuban strategy to prevent these infections has been an ini-
tial vaccination campaign continued through the NIP.
The first intervention was carried out in 1979 with an A+C
vaccine (Pasteur-Merieux) during the meningococcal dis-
ease epidemic caused mainly by serogroup C (50,0%) and
B (34,3%). The target population was 3, 245 046 individ-
uals from 3 months of age to 19 years old, considered at
high risk of disease, achieving 78.2% vaccination cover-
age. This intervention decreased significantly the sero-
group C (7.2%) in 1980, but was ineffective against
serogroup B, therefore the incidence continued to rise, but
having serogroup B as a predominant causal agent
(78.4%) [4,12].
By the end of 1988, after having being evaluated in a dou-
ble-blind, placebo-controlled trial, the Cuban anti-
meningococcal BC vaccine (VA-MENGOC B-C®) was first
administered to high risk age groups and subsequently to
all the population from 3 months of age to 24 years of age
(an estimated 2 million people or more) [4,9]. Since 1991
this vaccine has been included in the NIP for children of
3 months of life (2 doses, 2 months apart), decreasing the
nation-wide incidence of meningococcal meningitis to
below 1 per 100 000 population. For that reason, the con-
tribution of meningococcal meningitis to the overall inci-
dence of BM in Cuba is very small at present [13].
During this period, serogroup B Neisseria meningitidis
(classified by a commercial sera Wellcome Diagnostic,
England) has been the only one isolated bacteria and sub-
sequently confirmed by the Neisseria Laboratory at the
IPK, where the strain B4. P1. 19.15 has been the most fre-
quently identified, using ELISA [14]. It is likely due to the
fact that VA-MEMGOC B-C prevents the disease, but does
not eliminate the nasopharyngeal carriage [9].Page 4 of 7
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and/or strain into a region, country or continent depends
on the interaction of both the pathogen and the host
within settled environmental conditions, nevertheless
important changes may be induced by prolonged and
massive vaccination programmes.
Small children are widely considered a high-risk group for
BM, as it was confirmed in our study, where the highest
incidence was observed in less than 6 year olds. [15,16].
In Cuba Hib and Spn were the leading pathogens of BM
in this group since 1993, as a result of previous nation-
wide vaccination against meningococcus [5,12].
Due to the increase of infant mortality caused by Hib
infections, the PHM decided to start using an available
conjugate vaccine against Hib in 1999. The vaccine was
initially used in a campaign for small children and contin-
ued through the NIP [10]. The incidence of Hib meningi-
tis dropped by 47% after initial vaccination, especially in
small children, coinciding with reports in other countries
where those vaccines had also been used. Another benefi-
cial effect of conjugated Hib vaccine is the elimination of
carriage among vaccinated populations [17-19].
For these reasons, we considered that the vaccination
against Hib contributed decisively to the overall decrease
of BM in small children described above, and undoubt-
edly the development of such vaccines has been one of the
most important events in the history of the prevention
and control of infectious diseases in paediatrics [1,20].
Spn is not a common cause of meningitis epidemics and
outbreaks [21]. We considered that the steady low inci-
dence of meningococcal meningitis as well as the drastic
and significant reduction of Hib meningitis in small chil-
dren achieved during 1999 in Cuba, may have contrib-
uted to an increase of pneumococcal meningitis in 1999
and 2000, especially in children under 6 years old. We
hypothesised that Spn might have filled somehow the
ecological niche laid down abruptly by Hib after the inci-
dence decrease subsequent to vaccination. Since then Spn
is the leading cause of BM in Cuba as also occurs in many
regions of the world [22].
The improvement of the BM surveillance system in Cuba
increases substantially quantitative and qualitative infor-
mation about this group of infections [12]. Despite these
achievements, an important number of cases still remains
of unknown aetiology due to previous antibiotic therapy.
Regarding the gender, we observed in our study that infec-
tions in male predominated those in females, contrarily to
other author that point out non significant differences
between males and females [1].
CFR depends on, among other factors, the host response,
the virulence of the pathogen and the quality and timeli-
ness of medical attention. Average CFR was nearly 10%
and similar figures are reported in many developed coun-
tries, where it could be as low as 2% and as high as 25%
[23,24], though in developing countries it may be higher.
Pneumococcus was the most lethal germ, with CFR nearly
25%, and similar figures are reported in other regions of
the world [16,25,26].
Two well-defined seasons are recognised in Cuba: the
rainy (April to September) and the dry (October to
March). The monthly average case distribution of Hib and
pneumococcal meningitis, did not show seasonality dif-
ferences, but meningococcal meningitis did, increasing
the number of cases mainly in September, October and
March, coinciding with reports of the literature [3]. In
Cuba, September and October is the transitional period of
the rainy season to the dry, but also it is the end of the
summer vacations and the start of the school year, when
many children and adolescents share the same environ-
ment (DCC and schools) and are in close contact with one
another. Coincidence of these climatic, environmental
and socio-cultural conditions, undoubtedly may contrib-
ute to the seasonal increase of meningococcal meningitis
in our country.
Airborne transmission of infections can be favoured by
some environmental conditions such as attendance at
boarding institutions, overcrowding areas, poor ventila-
tion and intimate contact [3,15,27].
Seasonality of meningococcal meningitis in children and ado-lescentsFigure 1
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cases sleeping in overcrowded dormitories was 15%, but
in adolescents reached nearly 30%. It should be consid-
ered as an important risk for the transmission of BM in
this group, and must call the attention of both, MINED
and PHM, for the avoidance of these conditions, where
possible, especially in DCC and boarding school.
On the other hand, as a nation-wide improvement of the
Cuban educational system during the seventies, a huge
number of boarding school (Colleges, Technical and Pro-
fessional Education) were built nationwide. In these insti-
tutions the intimate contact and promiscuity among
boarding students may increase airborne infections
[3,15,27-29]. Nevertheless no strong association of BM
with attendance to boarding school or DCC was observed,
reinforcing the criteria of the beneficial effect of massive
and systematic vaccination against two of the main BM
causal pathogens.
Conclusion
Surveillance is a key subject for the control and prevention
of infectious diseases and provides information about
main epidemiological and microbiological aspects to put
in place correct strategies.
Massive vaccinations against meningococcus, and Hib
have decreased overall BM incidence in Cuba, and show-
ing Pneumococcus as the leading causal pathogen and the
most lethal.
The disease was more frequently observed among male
children under 6 years of age.
Seasonality was only observed in meningococcal menin-
gitis. Dry season and the start of the school year may also
be contributing environmental conditions.
There was a weak association of BM with attendance to
DCC and boarding school, and may be the effect of mas-
sive and systematic vaccination, which in our opinion are
the most adequate and effective measures for the preven-
tion and control of these infections.
Further massive vaccination initiatives with available anti-
pneumococcal conjugated vaccine (when economically
possible in Cuba) may decrease the incidence of BM even
more. Surveillance systems will contribute towards the
detection of the emergence of other causal pathogens or
any other changes in the epidemiology of these infections.
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